Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Peppermint oil in irritable bowel syndrome.

Grigoleit HG, Grigoleit P.

Phytomedicine. 2005 Aug;12(8):601-6. Review.

PMID:
16121521
2.

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.

Dig Liver Dis. 2007 Jun;39(6):530-6. Epub 2007 Apr 8.

PMID:
17420159
3.

Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.

Khanna R, MacDonald JK, Levesque BG.

J Clin Gastroenterol. 2014 Jul;48(6):505-12. doi: 10.1097/MCG.0b013e3182a88357. Review.

PMID:
24100754
4.
5.

Gastrointestinal clinical pharmacology of peppermint oil.

Grigoleit HG, Grigoleit P.

Phytomedicine. 2005 Aug;12(8):607-11. Review.

PMID:
16121522
6.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

7.

The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.

Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R.

Dig Dis Sci. 2010 May;55(5):1385-90. doi: 10.1007/s10620-009-0854-9. Epub 2009 Jun 9.

PMID:
19507027
8.

A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.

Cash BD, Epstein MS, Shah SM.

Dig Dis Sci. 2016 Feb;61(2):560-71. doi: 10.1007/s10620-015-3858-7. Epub 2015 Aug 29.

9.

Efficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study.

Alam MS, Roy PK, Miah AR, Mollick SH, Khan MR, Mahmud MC, Khatun S.

Mymensingh Med J. 2013 Jan;22(1):27-30.

PMID:
23416804
10.

Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):75-9.

PMID:
19585728
11.

Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.

Pittler MH, Ernst E.

Am J Gastroenterol. 1998 Jul;93(7):1131-5.

PMID:
9672344
12.

A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.

Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.

Am J Gastroenterol. 2010 Jan;105(1):170-7. doi: 10.1038/ajg.2009.577. Epub 2009 Oct 6.

PMID:
19809408
13.

Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.

Kline RM, Kline JJ, Di Palma J, Barbero GJ.

J Pediatr. 2001 Jan;138(1):125-8.

PMID:
11148527
14.

Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome.

Mosaffa-Jahromi M, Lankarani KB, Pasalar M, Afsharypuor S, Tamaddon AM.

J Ethnopharmacol. 2016 Dec 24;194:937-946. doi: 10.1016/j.jep.2016.10.083. Epub 2016 Nov 1.

PMID:
27815079
15.

Herbal remedies for dyspepsia: peppermint seems effective.

[No authors listed]

Prescrire Int. 2008 Jun;17(95):121-3.

PMID:
18630390
16.

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.

Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P.

BMJ. 2008 Nov 13;337:a2313. doi: 10.1136/bmj.a2313. Review. Erratum in: BMJ.2009;338:b1881.

17.

A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.).

McKay DL, Blumberg JB.

Phytother Res. 2006 Aug;20(8):619-33. Review.

PMID:
16767798
18.

Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.

Huertas-Ceballos A, Logan S, Bennett C, Macarthur C.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003017. doi: 10.1002/14651858.CD003017.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD003017.

PMID:
18254013
19.

[Dinggui Oil Capsule in treating irritable bowel syndrome with stagnation of qi and cold: a prospective, multi-center, randomized, placebo-controlled, double-blind trial].

Zhang RM, Wang L, Yang XN, Xia Q, Jiang MD, Fan ZJ, Zhang FX, Zhang HR, Yu Z, Li TQ.

Zhong Xi Yi Jie He Xue Bao. 2007 Jul;5(4):392-7. Chinese.

20.

Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.

Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.

Am J Gastroenterol. 2008 Oct;103(10):2562-9. doi: 10.1111/j.1572-0241.2008.02115.x. Epub 2008 Sep 4.

PMID:
18775020

Supplemental Content

Support Center